Dual modulators of 5HT2A and D3 receptors
US8829029B2 · kind B2 · utility
1Cited by
8References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2013 |
| Grant date | Sep 9, 2014 |
| Priority date | — |
| Expiry date | Feb 21, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the formula (I)wherein R1, R2, X and n are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the treatment of psychotic disorders, as well as other diseases such as depression and anxiety, drug dependence, dementias and memory impairment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.